Icon

TRUSELTIQ - (25MG, 100MG)

INFIGRATINIB PHOSPHATE None
25MG, 100MG
Less Than $1000 mn
None None
None None
None None
TRUSELTIQ is a kinase inhibitor indicated for the treatment of adults with previously treated, unresectable locally advanced or metastatic cholangiocarcinoma with a fibroblast growth factor receptor 2 (FGFR2) fusion or other rearrangement as detected by an FDA-approved test.
Yes
TRUSELTIQ Patent 1 Patent 2 Patent 3 Patent 4
*** *********

Download ParaIV Report


Download ParaIV Detailed Report


To get detailed report Contact Us

ParaIV Advanced Search






Drug Name Generic Name Dosage Route of Administration Probable FTF Known Para IV Filers Other ANDA Developers

Please contact contact@researchdelta.com to get more details.